4-(2-Methoxypropan-2-yl)piperidine → 4-(2-chloro-8-((4-(2-methoxypropan-2-yl)piperidin-1-yl)methyl)-9-methyl-9H-purin-6-yl)morpholine
반응식
[Br:12][CH2:13][c:14]1[n:15]([CH3:30])[c:16]2[n:17][c:18]([Cl:29])[n:19][c:20]([N:23]3[CH2:24][CH2:25][O:26][CH2:27][CH2:28]3)[c:21]2[n:22]1.[CH3:1][O:2][C:3]([CH3:4])([CH3:5])[CH:6]1[CH2:7][CH2:8][NH:9][CH2:10][CH2:11]1>>[CH3:1][O:2][C:3]([CH3:4])([CH3:5])[CH:6]1[CH2:7][CH2:8][N:9]([CH2:13][c:14]2[n:15]([CH3:30])[c:16]3[n:17][c:18]([Cl:29])[n:19][c:20]([N:23]4[CH2:24][CH2:25][O:26][CH2:27][CH2:28]4)[c:21]3[n:22]2)[CH2:10][CH2:11]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-5ed88947b214431abd8d4f9b8ae19cc1
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (5/10)
반응 노트
불러오는 중…